Caplight Directory>Companies>Novasenta-preview>Novasenta


Novasenta

Novasenta

Private
Pittsburgh, PennsylvaniaHealthcare & Life Scienceswww.novasenta.com

Last Round

Series A

Jul 29, 2022

Total Funding Raised

$60M

Company Overview

Novasenta is a biotechnology company that develops innovative immuno-oncology therapeutics and utilizes a machine-learning platform to discover potential drug targets within the tumor microenvironment, aiming to provide safer and more effective cancer treatments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

antibody therapeuticstumor microenvironmentTMEdrug discovery platformsingle-cell analysisimmuno-oncologycancer therapeuticsimmunotherapydrug discoverynovel drug targetsfirst-in-class therapeuticsplatform biotechcancer-associated fibroblastsCAFsstromal cellspreclinical biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novasenta Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Novasenta Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJul 29, 2022
SeedAug 23, 2021
View all Funding Rounds

Novasenta Investors

Notable investors and investment history

InvestorRounds
UPMCSeries A
UPMC EnterprisesSeed, Series A
View all Investors

Novasenta Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Novasenta Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Novasenta's valuation, stock price, and market status.

Firmographic Details

HeadquartersPittsburgh, Pennsylvania
Employee Range17
Year Founded2018
Last FundingJul 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.